
The Consortium for iNKT Research and Therapy (CiRT) is a coalition of investigators with interests in iNKT research and clinical translation. The CiRT aims to further the development of iNKT-based technologies, including cell and gene therapies to improve the outcomes of cancers, organ and bone marrow transplantation, infectious diseases and autoimmune disorders.
Annual Revenue$1M to $5M
Estimated OwnershipNonprofitBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.